Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOSL2
|
ENSG00000075426.12 | FOSL2 |
SMARCC1
|
ENSG00000173473.11 | SMARCC1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOSL2 | hg38_v1_chr2_+_28395511_28395743 | 0.81 | 5.9e-08 | Click! |
SMARCC1 | hg38_v1_chr3_-_47781837_47781908 | -0.38 | 4.1e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_23873000 | 23.17 |
ENST00000269217.11
ENST00000587184.5 |
LAMA3
|
laminin subunit alpha 3 |
chr1_+_150508074 | 20.83 |
ENST00000369049.8
|
ECM1
|
extracellular matrix protein 1 |
chr1_+_150508099 | 20.71 |
ENST00000346569.6
ENST00000369047.9 |
ECM1
|
extracellular matrix protein 1 |
chr19_-_35528221 | 20.34 |
ENST00000588674.5
ENST00000452271.7 ENST00000518157.1 |
SBSN
|
suprabasin |
chr17_-_41612757 | 15.68 |
ENST00000301653.9
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr1_-_153549120 | 12.37 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr2_+_113117889 | 11.71 |
ENST00000361779.7
ENST00000259206.9 ENST00000354115.6 |
IL1RN
|
interleukin 1 receptor antagonist |
chr1_-_153057504 | 10.45 |
ENST00000392653.3
|
SPRR2A
|
small proline rich protein 2A |
chr6_+_73695779 | 10.14 |
ENST00000422508.6
ENST00000437994.6 |
CD109
|
CD109 molecule |
chr6_+_73696145 | 9.97 |
ENST00000287097.6
|
CD109
|
CD109 molecule |
chr1_-_153549238 | 9.90 |
ENST00000368713.8
|
S100A3
|
S100 calcium binding protein A3 |
chr1_-_153094521 | 9.37 |
ENST00000368750.8
|
SPRR2E
|
small proline rich protein 2E |
chr11_-_65900375 | 9.34 |
ENST00000312562.7
|
FOSL1
|
FOS like 1, AP-1 transcription factor subunit |
chr12_-_121800558 | 9.33 |
ENST00000546227.5
|
RHOF
|
ras homolog family member F, filopodia associated |
chr19_-_50969567 | 8.93 |
ENST00000310157.7
|
KLK6
|
kallikrein related peptidase 6 |
chr12_+_53098846 | 8.68 |
ENST00000650247.1
ENST00000549628.1 |
IGFBP6
|
insulin like growth factor binding protein 6 |
chr12_-_119804298 | 8.39 |
ENST00000678652.1
ENST00000678494.1 |
CIT
|
citron rho-interacting serine/threonine kinase |
chr12_-_119804472 | 8.39 |
ENST00000678087.1
ENST00000677993.1 |
CIT
|
citron rho-interacting serine/threonine kinase |
chr15_-_74212219 | 8.31 |
ENST00000449139.6
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
chr11_-_65900413 | 8.10 |
ENST00000448083.6
ENST00000531493.5 ENST00000532401.1 |
FOSL1
|
FOS like 1, AP-1 transcription factor subunit |
chr6_+_47698538 | 7.44 |
ENST00000327753.7
|
ADGRF4
|
adhesion G protein-coupled receptor F4 |
chr18_+_63775395 | 7.39 |
ENST00000398019.7
|
SERPINB7
|
serpin family B member 7 |
chr6_+_47698574 | 7.30 |
ENST00000283303.3
|
ADGRF4
|
adhesion G protein-coupled receptor F4 |
chr18_+_63775369 | 7.26 |
ENST00000540675.5
|
SERPINB7
|
serpin family B member 7 |
chr12_-_95116967 | 6.92 |
ENST00000551521.5
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr1_-_153113507 | 6.87 |
ENST00000468739.2
|
SPRR2F
|
small proline rich protein 2F |
chr18_+_36544544 | 6.80 |
ENST00000591635.5
|
FHOD3
|
formin homology 2 domain containing 3 |
chr11_-_62556230 | 6.75 |
ENST00000530285.5
|
AHNAK
|
AHNAK nucleoprotein |
chr3_-_48595267 | 6.65 |
ENST00000328333.12
ENST00000681320.1 |
COL7A1
|
collagen type VII alpha 1 chain |
chr9_+_137225166 | 6.55 |
ENST00000650725.2
|
CYSRT1
|
cysteine rich tail 1 |
chr5_-_177496845 | 6.50 |
ENST00000506537.1
|
PDLIM7
|
PDZ and LIM domain 7 |
chr7_+_48088596 | 6.42 |
ENST00000416681.5
ENST00000331803.8 ENST00000432131.5 |
UPP1
|
uridine phosphorylase 1 |
chr12_+_13196718 | 6.22 |
ENST00000431267.2
ENST00000542474.5 ENST00000544053.5 ENST00000256951.10 |
EMP1
|
epithelial membrane protein 1 |
chr5_-_177496802 | 6.08 |
ENST00000506161.5
|
PDLIM7
|
PDZ and LIM domain 7 |
chr11_-_6320494 | 5.93 |
ENST00000303927.4
ENST00000530979.1 |
CAVIN3
|
caveolae associated protein 3 |
chr21_-_26843012 | 5.89 |
ENST00000517777.6
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
chr19_-_35501878 | 5.80 |
ENST00000593342.5
ENST00000601650.1 ENST00000408915.6 |
DMKN
|
dermokine |
chr21_-_26843063 | 5.75 |
ENST00000678221.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
chr19_-_51034840 | 5.71 |
ENST00000529888.5
|
KLK12
|
kallikrein related peptidase 12 |
chr12_-_94616061 | 5.62 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr19_-_51034892 | 5.61 |
ENST00000319590.8
ENST00000250351.4 |
KLK12
|
kallikrein related peptidase 12 |
chr17_+_4950147 | 5.59 |
ENST00000522301.5
|
ENO3
|
enolase 3 |
chr10_+_17228215 | 5.54 |
ENST00000544301.7
|
VIM
|
vimentin |
chr20_-_653189 | 5.49 |
ENST00000381962.4
|
SRXN1
|
sulfiredoxin 1 |
chr8_+_10672623 | 5.32 |
ENST00000304519.10
|
C8orf74
|
chromosome 8 open reading frame 74 |
chr11_-_66336396 | 5.32 |
ENST00000627248.1
ENST00000311320.9 |
RIN1
|
Ras and Rab interactor 1 |
chr19_-_51034993 | 5.30 |
ENST00000684732.1
|
KLK12
|
kallikrein related peptidase 12 |
chr5_+_136059151 | 5.29 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor beta induced |
chr19_-_35513641 | 5.26 |
ENST00000339686.8
ENST00000447113.6 |
DMKN
|
dermokine |
chr7_+_143381286 | 5.22 |
ENST00000449630.5
ENST00000322764.10 ENST00000457235.5 |
ZYX
|
zyxin |
chr13_+_77535681 | 5.15 |
ENST00000349847.4
|
SCEL
|
sciellin |
chr13_+_77535742 | 5.12 |
ENST00000377246.7
|
SCEL
|
sciellin |
chr13_+_77535669 | 5.10 |
ENST00000535157.5
|
SCEL
|
sciellin |
chr11_-_102798148 | 4.94 |
ENST00000315274.7
|
MMP1
|
matrix metallopeptidase 1 |
chr19_+_38789198 | 4.84 |
ENST00000314980.5
|
LGALS7B
|
galectin 7B |
chr1_+_154405326 | 4.77 |
ENST00000368485.8
|
IL6R
|
interleukin 6 receptor |
chr19_-_51020154 | 4.71 |
ENST00000391805.5
ENST00000599077.1 |
KLK10
|
kallikrein related peptidase 10 |
chr5_+_150497772 | 4.69 |
ENST00000523767.5
|
NDST1
|
N-deacetylase and N-sulfotransferase 1 |
chr1_+_183186238 | 4.66 |
ENST00000493293.5
ENST00000264144.5 |
LAMC2
|
laminin subunit gamma 2 |
chr20_+_35172046 | 4.60 |
ENST00000216968.5
|
PROCR
|
protein C receptor |
chr17_-_42423246 | 4.58 |
ENST00000357037.6
|
CAVIN1
|
caveolae associated protein 1 |
chr2_-_112784486 | 4.53 |
ENST00000263339.4
|
IL1A
|
interleukin 1 alpha |
chr16_-_30113528 | 4.52 |
ENST00000406256.8
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr15_+_67128103 | 4.43 |
ENST00000558894.5
|
SMAD3
|
SMAD family member 3 |
chr20_+_37383648 | 4.24 |
ENST00000373567.6
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase |
chr3_-_98522514 | 4.14 |
ENST00000503004.5
ENST00000506575.1 ENST00000513452.5 ENST00000515620.5 |
CLDND1
|
claudin domain containing 1 |
chr1_-_204151884 | 4.11 |
ENST00000367201.7
|
ETNK2
|
ethanolamine kinase 2 |
chr9_+_35673917 | 4.06 |
ENST00000617161.1
ENST00000378357.9 |
CA9
|
carbonic anhydrase 9 |
chr1_+_154405193 | 4.05 |
ENST00000622330.4
ENST00000344086.8 |
IL6R
|
interleukin 6 receptor |
chr19_-_51020019 | 3.89 |
ENST00000309958.7
|
KLK10
|
kallikrein related peptidase 10 |
chr6_+_41637005 | 3.81 |
ENST00000419164.6
ENST00000373051.6 |
MDFI
|
MyoD family inhibitor |
chr15_-_74212256 | 3.80 |
ENST00000416286.7
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
chrX_+_136169624 | 3.79 |
ENST00000394153.6
|
FHL1
|
four and a half LIM domains 1 |
chr1_-_204152010 | 3.69 |
ENST00000367202.9
|
ETNK2
|
ethanolamine kinase 2 |
chrX_+_136169833 | 3.68 |
ENST00000628032.2
|
FHL1
|
four and a half LIM domains 1 |
chr1_-_159954213 | 3.63 |
ENST00000368092.7
ENST00000368093.4 |
SLAMF9
|
SLAM family member 9 |
chr15_-_79971164 | 3.61 |
ENST00000335661.6
ENST00000267953.4 ENST00000677151.1 |
BCL2A1
|
BCL2 related protein A1 |
chr7_-_108003122 | 3.56 |
ENST00000393559.2
ENST00000222399.11 ENST00000676777.1 ENST00000439976.6 ENST00000393560.5 ENST00000677793.1 ENST00000679244.1 |
LAMB1
|
laminin subunit beta 1 |
chr17_+_76385256 | 3.56 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
chr19_-_43781249 | 3.48 |
ENST00000615047.4
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
chr1_-_28193873 | 3.48 |
ENST00000305392.3
ENST00000539896.1 |
PTAFR
|
platelet activating factor receptor |
chr18_+_63777773 | 3.46 |
ENST00000447428.5
ENST00000546027.5 |
SERPINB7
|
serpin family B member 7 |
chr15_+_67166019 | 3.45 |
ENST00000537194.6
|
SMAD3
|
SMAD family member 3 |
chrX_+_136169664 | 3.43 |
ENST00000456445.5
|
FHL1
|
four and a half LIM domains 1 |
chr1_+_26280117 | 3.43 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamate rich protein like 3 |
chr1_-_156705575 | 3.42 |
ENST00000368222.8
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr17_-_7590072 | 3.42 |
ENST00000538513.6
ENST00000570788.1 ENST00000250055.3 |
SOX15
|
SRY-box transcription factor 15 |
chr16_+_58500135 | 3.39 |
ENST00000563978.5
ENST00000569923.5 ENST00000356752.8 ENST00000563799.5 ENST00000562999.5 ENST00000570248.5 ENST00000562731.5 ENST00000568424.1 |
NDRG4
|
NDRG family member 4 |
chr10_-_88851809 | 3.37 |
ENST00000371930.5
|
ANKRD22
|
ankyrin repeat domain 22 |
chr4_-_39032343 | 3.37 |
ENST00000381938.4
|
TMEM156
|
transmembrane protein 156 |
chr19_-_43780957 | 3.35 |
ENST00000648319.1
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
chr19_-_51065067 | 3.33 |
ENST00000595547.5
ENST00000335422.3 ENST00000595793.6 ENST00000596955.1 |
KLK13
|
kallikrein related peptidase 13 |
chr19_-_43670153 | 3.33 |
ENST00000601723.5
ENST00000339082.7 ENST00000340093.8 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr3_+_191329020 | 3.31 |
ENST00000392456.4
|
CCDC50
|
coiled-coil domain containing 50 |
chr20_+_46008900 | 3.22 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 |
chr7_+_26291850 | 3.14 |
ENST00000338523.9
ENST00000446848.6 |
SNX10
|
sorting nexin 10 |
chr4_+_73740541 | 3.13 |
ENST00000401931.1
ENST00000307407.8 |
CXCL8
|
C-X-C motif chemokine ligand 8 |
chr18_+_58671517 | 3.13 |
ENST00000345724.7
|
MALT1
|
MALT1 paracaspase |
chr9_-_35112379 | 3.12 |
ENST00000488109.6
|
FAM214B
|
family with sequence similarity 214 member B |
chr16_+_50266530 | 3.12 |
ENST00000566433.6
ENST00000394697.7 ENST00000673801.1 |
ADCY7
|
adenylate cyclase 7 |
chr12_-_48865863 | 3.02 |
ENST00000309739.6
|
RND1
|
Rho family GTPase 1 |
chr2_+_90021567 | 3.01 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr12_-_47758828 | 2.94 |
ENST00000389212.7
ENST00000449771.7 |
RAPGEF3
|
Rap guanine nucleotide exchange factor 3 |
chrX_+_100644183 | 2.92 |
ENST00000640889.1
ENST00000373004.5 |
SRPX2
|
sushi repeat containing protein X-linked 2 |
chr8_-_142614469 | 2.92 |
ENST00000356613.4
|
ARC
|
activity regulated cytoskeleton associated protein |
chr11_+_62881686 | 2.90 |
ENST00000536981.6
ENST00000539891.6 |
SLC3A2
|
solute carrier family 3 member 2 |
chr6_-_35921047 | 2.82 |
ENST00000361690.7
ENST00000512445.5 |
SRPK1
|
SRSF protein kinase 1 |
chr3_-_12759224 | 2.80 |
ENST00000314124.12
ENST00000435218.6 ENST00000435575.5 |
TMEM40
|
transmembrane protein 40 |
chr19_-_43198079 | 2.80 |
ENST00000597374.5
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
chrX_+_49171889 | 2.78 |
ENST00000376327.6
|
PLP2
|
proteolipid protein 2 |
chr11_-_64246190 | 2.77 |
ENST00000392210.6
|
PPP1R14B
|
protein phosphatase 1 regulatory inhibitor subunit 14B |
chr17_-_29176752 | 2.76 |
ENST00000533112.5
|
MYO18A
|
myosin XVIIIA |
chr6_+_106098933 | 2.75 |
ENST00000369089.3
|
PRDM1
|
PR/SET domain 1 |
chr15_+_67125707 | 2.75 |
ENST00000540846.6
|
SMAD3
|
SMAD family member 3 |
chrX_+_136169891 | 2.70 |
ENST00000449474.5
|
FHL1
|
four and a half LIM domains 1 |
chr16_-_72620 | 2.69 |
ENST00000262316.10
|
RHBDF1
|
rhomboid 5 homolog 1 |
chr6_+_32153441 | 2.68 |
ENST00000414204.5
ENST00000361568.6 ENST00000395523.5 |
PPT2
|
palmitoyl-protein thioesterase 2 |
chr8_+_86098901 | 2.66 |
ENST00000285393.4
|
ATP6V0D2
|
ATPase H+ transporting V0 subunit d2 |
chr8_+_125430333 | 2.62 |
ENST00000311922.4
|
TRIB1
|
tribbles pseudokinase 1 |
chr19_-_38773432 | 2.61 |
ENST00000599035.1
ENST00000378626.5 |
LGALS7
|
galectin 7 |
chr9_-_107489754 | 2.59 |
ENST00000610832.1
ENST00000374672.5 |
KLF4
|
Kruppel like factor 4 |
chr17_+_7579491 | 2.56 |
ENST00000380498.10
ENST00000584502.1 ENST00000250092.11 |
CD68
|
CD68 molecule |
chr1_+_156126160 | 2.53 |
ENST00000448611.6
ENST00000368297.5 |
LMNA
|
lamin A/C |
chr2_+_90069662 | 2.53 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr5_+_136058849 | 2.53 |
ENST00000508076.5
|
TGFBI
|
transforming growth factor beta induced |
chr11_+_844406 | 2.49 |
ENST00000397404.5
|
TSPAN4
|
tetraspanin 4 |
chr4_-_39032922 | 2.47 |
ENST00000344606.6
|
TMEM156
|
transmembrane protein 156 |
chr17_+_75721327 | 2.45 |
ENST00000579662.5
|
ITGB4
|
integrin subunit beta 4 |
chr11_+_35176696 | 2.39 |
ENST00000528455.5
|
CD44
|
CD44 molecule (Indian blood group) |
chr1_+_154325512 | 2.39 |
ENST00000368489.6
ENST00000368487.7 |
ATP8B2
|
ATPase phospholipid transporting 8B2 |
chr6_-_35921079 | 2.38 |
ENST00000507909.1
ENST00000373825.7 |
SRPK1
|
SRSF protein kinase 1 |
chr4_-_174522791 | 2.38 |
ENST00000541923.5
ENST00000542498.5 |
HPGD
|
15-hydroxyprostaglandin dehydrogenase |
chr11_+_35618450 | 2.38 |
ENST00000317811.6
|
FJX1
|
four-jointed box kinase 1 |
chr10_+_73911104 | 2.37 |
ENST00000446342.5
ENST00000372764.4 |
PLAU
|
plasminogen activator, urokinase |
chr6_-_130956371 | 2.36 |
ENST00000639623.1
ENST00000525193.5 ENST00000527659.5 |
EPB41L2
|
erythrocyte membrane protein band 4.1 like 2 |
chr18_+_54828406 | 2.35 |
ENST00000262094.10
|
RAB27B
|
RAB27B, member RAS oncogene family |
chr6_-_35921128 | 2.35 |
ENST00000510290.5
ENST00000423325.6 |
SRPK1
|
SRSF protein kinase 1 |
chrX_-_15664798 | 2.32 |
ENST00000380342.4
|
CLTRN
|
collectrin, amino acid transport regulator |
chr11_+_394196 | 2.30 |
ENST00000331563.7
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
chr17_+_75721471 | 2.30 |
ENST00000450894.7
|
ITGB4
|
integrin subunit beta 4 |
chr18_+_63587336 | 2.30 |
ENST00000344731.10
|
SERPINB13
|
serpin family B member 13 |
chr9_-_35685462 | 2.29 |
ENST00000607559.1
|
TPM2
|
tropomyosin 2 |
chr11_+_73289403 | 2.26 |
ENST00000535931.2
ENST00000544437.6 |
P2RY6
|
pyrimidinergic receptor P2Y6 |
chr7_+_134843884 | 2.24 |
ENST00000445569.6
|
CALD1
|
caldesmon 1 |
chr12_-_76084612 | 2.23 |
ENST00000535020.6
ENST00000552342.5 |
NAP1L1
|
nucleosome assembly protein 1 like 1 |
chr11_-_118264445 | 2.19 |
ENST00000438295.2
|
MPZL2
|
myelin protein zero like 2 |
chr22_-_32159301 | 2.18 |
ENST00000382097.4
|
C22orf42
|
chromosome 22 open reading frame 42 |
chr7_+_130293134 | 2.18 |
ENST00000445470.6
ENST00000492072.5 ENST00000222482.10 ENST00000473956.5 ENST00000493259.5 ENST00000486598.1 |
CPA4
|
carboxypeptidase A4 |
chr1_-_150235972 | 2.17 |
ENST00000534220.1
|
ANP32E
|
acidic nuclear phosphoprotein 32 family member E |
chr12_-_57520480 | 2.16 |
ENST00000642841.1
ENST00000547303.5 ENST00000552740.5 ENST00000547526.1 ENST00000346473.8 ENST00000551116.5 |
ENSG00000285133.1
DDIT3
|
novel protein DNA damage inducible transcript 3 |
chr20_-_1329131 | 2.11 |
ENST00000360779.4
|
SDCBP2
|
syndecan binding protein 2 |
chr11_+_35176575 | 2.09 |
ENST00000526000.6
|
CD44
|
CD44 molecule (Indian blood group) |
chr3_+_11137093 | 2.08 |
ENST00000438284.2
|
HRH1
|
histamine receptor H1 |
chr2_+_219627650 | 2.06 |
ENST00000317151.7
|
SLC4A3
|
solute carrier family 4 member 3 |
chr16_+_58500047 | 2.05 |
ENST00000566192.5
ENST00000565088.5 ENST00000568640.5 |
NDRG4
|
NDRG family member 4 |
chr2_+_190927649 | 2.03 |
ENST00000409428.5
ENST00000409215.5 |
GLS
|
glutaminase |
chr11_+_35176639 | 2.03 |
ENST00000527889.6
|
CD44
|
CD44 molecule (Indian blood group) |
chr9_-_127578989 | 2.03 |
ENST00000373314.7
|
NIBAN2
|
niban apoptosis regulator 2 |
chr22_-_37188281 | 2.03 |
ENST00000397110.6
|
C1QTNF6
|
C1q and TNF related 6 |
chr5_-_177497561 | 2.02 |
ENST00000359895.6
ENST00000355572.6 ENST00000393551.5 ENST00000505074.5 ENST00000393546.8 ENST00000355841.7 |
PDLIM7
|
PDZ and LIM domain 7 |
chr11_+_35176611 | 2.02 |
ENST00000279452.10
|
CD44
|
CD44 molecule (Indian blood group) |
chr2_+_219627565 | 2.01 |
ENST00000273063.10
|
SLC4A3
|
solute carrier family 4 member 3 |
chr1_-_151992571 | 2.01 |
ENST00000368809.1
|
S100A10
|
S100 calcium binding protein A10 |
chr3_-_149377637 | 1.99 |
ENST00000305366.8
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr8_-_67746348 | 1.97 |
ENST00000297770.10
|
CPA6
|
carboxypeptidase A6 |
chr2_+_219627622 | 1.97 |
ENST00000358055.8
|
SLC4A3
|
solute carrier family 4 member 3 |
chr11_-_82997477 | 1.94 |
ENST00000534301.5
|
RAB30
|
RAB30, member RAS oncogene family |
chr1_+_36155930 | 1.90 |
ENST00000316156.8
|
MAP7D1
|
MAP7 domain containing 1 |
chr6_-_30744537 | 1.89 |
ENST00000259874.6
ENST00000376377.2 |
IER3
|
immediate early response 3 |
chr1_-_243843164 | 1.89 |
ENST00000491219.6
ENST00000680056.1 ENST00000492957.2 |
AKT3
|
AKT serine/threonine kinase 3 |
chr3_+_155080088 | 1.89 |
ENST00000462745.5
|
MME
|
membrane metalloendopeptidase |
chr3_+_172754457 | 1.89 |
ENST00000441497.6
|
ECT2
|
epithelial cell transforming 2 |
chr17_-_19004727 | 1.86 |
ENST00000388995.11
|
FAM83G
|
family with sequence similarity 83 member G |
chr2_-_89160329 | 1.85 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr18_+_24155938 | 1.82 |
ENST00000582229.1
|
CABYR
|
calcium binding tyrosine phosphorylation regulated |
chr1_-_27490130 | 1.80 |
ENST00000618852.5
|
WASF2
|
WASP family member 2 |
chr20_+_36154630 | 1.78 |
ENST00000338074.7
ENST00000636016.2 ENST00000373945.5 |
EPB41L1
|
erythrocyte membrane protein band 4.1 like 1 |
chr15_+_73873557 | 1.78 |
ENST00000300504.7
|
TBC1D21
|
TBC1 domain family member 21 |
chr6_-_43629222 | 1.77 |
ENST00000307126.10
|
GTPBP2
|
GTP binding protein 2 |
chr22_+_20507571 | 1.77 |
ENST00000414658.5
ENST00000432052.5 ENST00000292733.11 ENST00000263205.11 ENST00000406969.5 |
MED15
|
mediator complex subunit 15 |
chr18_+_58671439 | 1.76 |
ENST00000649217.2
|
MALT1
|
MALT1 paracaspase |
chr1_-_150235995 | 1.75 |
ENST00000436748.6
|
ANP32E
|
acidic nuclear phosphoprotein 32 family member E |
chr1_-_154970735 | 1.75 |
ENST00000368445.9
ENST00000448116.7 ENST00000368449.8 |
SHC1
|
SHC adaptor protein 1 |
chr8_-_109975757 | 1.75 |
ENST00000524391.6
|
KCNV1
|
potassium voltage-gated channel modifier subfamily V member 1 |
chr17_-_1486124 | 1.74 |
ENST00000575158.5
|
MYO1C
|
myosin IC |
chr1_+_36156096 | 1.74 |
ENST00000474796.2
ENST00000373150.8 ENST00000373151.6 |
MAP7D1
|
MAP7 domain containing 1 |
chr2_+_169069537 | 1.73 |
ENST00000428522.5
ENST00000450153.1 ENST00000674881.1 ENST00000421653.5 |
DHRS9
|
dehydrogenase/reductase 9 |
chr2_+_89851723 | 1.73 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr1_-_150235943 | 1.70 |
ENST00000533654.5
|
ANP32E
|
acidic nuclear phosphoprotein 32 family member E |
chr19_+_926001 | 1.70 |
ENST00000263620.8
|
ARID3A
|
AT-rich interaction domain 3A |
chr4_-_993430 | 1.68 |
ENST00000361661.6
ENST00000622731.4 |
SLC26A1
|
solute carrier family 26 member 1 |
chr1_+_156893678 | 1.67 |
ENST00000292357.8
ENST00000338302.7 ENST00000455314.5 |
PEAR1
|
platelet endothelial aggregation receptor 1 |
chr1_+_966466 | 1.66 |
ENST00000379410.8
ENST00000379407.7 ENST00000379409.6 |
PLEKHN1
|
pleckstrin homology domain containing N1 |
chr2_+_89959979 | 1.63 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chrX_+_49171918 | 1.62 |
ENST00000376322.7
|
PLP2
|
proteolipid protein 2 |
chrX_-_15493234 | 1.62 |
ENST00000380420.10
|
PIR
|
pirin |
chr12_+_56128217 | 1.62 |
ENST00000267113.4
ENST00000394048.10 |
ESYT1
|
extended synaptotagmin 1 |
chr14_-_24337382 | 1.62 |
ENST00000555591.1
ENST00000554569.1 |
ENSG00000258973.1
RIPK3
|
novel transcript receptor interacting serine/threonine kinase 3 |
chr15_-_25865076 | 1.61 |
ENST00000619904.1
|
ATP10A
|
ATPase phospholipid transporting 10A (putative) |
chr1_+_155033824 | 1.59 |
ENST00000295542.6
ENST00000423025.6 ENST00000368419.2 |
DCST1
|
DC-STAMP domain containing 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 18.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
3.6 | 18.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
2.9 | 17.4 | GO:0007296 | vitellogenesis(GO:0007296) |
2.8 | 11.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
2.1 | 6.4 | GO:0046108 | uridine metabolic process(GO:0046108) |
2.1 | 8.6 | GO:0002384 | hepatic immune response(GO:0002384) |
2.0 | 12.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
2.0 | 5.9 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
1.8 | 10.6 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
1.4 | 41.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.3 | 36.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.3 | 8.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.2 | 3.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
1.1 | 3.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.1 | 3.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
1.1 | 3.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
1.0 | 3.0 | GO:0044007 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
0.9 | 18.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.9 | 2.8 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.9 | 2.8 | GO:1990654 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
0.9 | 3.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.9 | 2.6 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.8 | 4.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.8 | 4.9 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.8 | 2.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 3.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.7 | 8.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.7 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 5.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.6 | 4.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 7.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.6 | 4.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 8.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.5 | 1.6 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.5 | 2.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 1.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.5 | 2.0 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.5 | 6.6 | GO:0046541 | saliva secretion(GO:0046541) |
0.5 | 2.9 | GO:0060356 | leucine import(GO:0060356) |
0.4 | 2.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.4 | 3.5 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.4 | 6.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 4.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.4 | 1.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 1.3 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.4 | 2.9 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 26.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 3.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 1.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 5.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 3.0 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 1.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 1.1 | GO:1990009 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
0.4 | 2.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.4 | 1.4 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.4 | 0.7 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
0.4 | 1.1 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.3 | 6.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
0.3 | 2.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.3 | 1.0 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 5.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 18.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 7.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 3.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.3 | 0.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 1.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 3.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 2.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 0.8 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.3 | 6.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 2.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 8.9 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 0.7 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.2 | 0.7 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.2 | 0.9 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 8.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 1.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 2.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 2.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 1.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 1.8 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.2 | 1.7 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 1.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 2.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 1.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 5.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 2.0 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.2 | 0.6 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 1.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 2.3 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 2.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 0.6 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.2 | 2.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.2 | 9.5 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.2 | 9.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 3.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.2 | 3.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 3.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 1.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 3.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 16.7 | GO:0070268 | cornification(GO:0070268) |
0.2 | 13.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 2.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 8.1 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 9.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 3.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.4 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 1.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 1.9 | GO:0097107 | postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 13.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.4 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 1.2 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 4.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 2.5 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 1.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.7 | GO:0060750 | antral ovarian follicle growth(GO:0001547) mammary gland branching involved in pregnancy(GO:0060745) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 1.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.8 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 2.5 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 1.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 4.6 | GO:0009303 | termination of RNA polymerase I transcription(GO:0006363) rRNA transcription(GO:0009303) |
0.1 | 0.3 | GO:1901656 | glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
0.1 | 0.8 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.1 | GO:0060440 | trachea formation(GO:0060440) |
0.1 | 0.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 3.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 1.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 1.6 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.1 | 10.3 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 0.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 4.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 4.8 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.1 | 1.5 | GO:0060294 | inner dynein arm assembly(GO:0036159) cilium movement involved in cell motility(GO:0060294) |
0.1 | 2.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 1.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 4.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.1 | 1.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 3.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.8 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 1.2 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 1.7 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 1.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 5.6 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 1.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 3.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 2.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 2.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 2.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.8 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.8 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 1.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 1.2 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 2.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 1.8 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 2.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 1.1 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 0.1 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.0 | 4.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 2.0 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 1.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.0 | 0.2 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 2.7 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.9 | GO:0003231 | cardiac ventricle development(GO:0003231) |
0.0 | 0.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.4 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 1.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.5 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 1.8 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.0 | 0.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 1.2 | GO:0006096 | glycolytic process(GO:0006096) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 2.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.0 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 24.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.1 | 41.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
1.8 | 3.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.7 | 8.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.6 | 4.7 | GO:0043256 | laminin complex(GO:0043256) |
1.2 | 10.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.1 | 6.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
1.0 | 4.9 | GO:0032449 | CBM complex(GO:0032449) |
0.8 | 8.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.8 | 2.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.7 | 43.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.7 | 8.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.7 | 2.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.7 | 6.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 3.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 1.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.5 | 19.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 1.8 | GO:0097229 | sperm end piece(GO:0097229) |
0.4 | 1.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.4 | 8.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 3.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 1.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 2.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 4.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 0.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 5.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.4 | GO:0002081 | inner acrosomal membrane(GO:0002079) outer acrosomal membrane(GO:0002081) |
0.2 | 2.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 3.7 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.6 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.2 | 9.9 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.6 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.2 | 3.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 5.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 17.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 4.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 3.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 2.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 3.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 3.4 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 2.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 22.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 17.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 17.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 1.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 13.9 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 4.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 2.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.2 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 0.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.1 | 2.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.3 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 0.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 2.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 5.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 2.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 7.3 | GO:0005901 | caveola(GO:0005901) |
0.1 | 18.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 14.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0055028 | cortical microtubule(GO:0055028) |
0.0 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 19.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 2.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 2.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 48.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 10.0 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 1.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.0 | GO:0005903 | brush border(GO:0005903) |
0.0 | 2.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 1.4 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.0 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.6 | GO:0016363 | nuclear matrix(GO:0016363) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 41.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
3.9 | 11.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.9 | 8.8 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
2.1 | 6.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.8 | 10.6 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
1.2 | 4.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
1.1 | 4.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.1 | 6.8 | GO:1990254 | keratin filament binding(GO:1990254) |
1.1 | 7.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.8 | 3.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.7 | 8.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 9.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.7 | 6.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 6.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 4.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.6 | 1.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.5 | 21.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 2.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.5 | 3.6 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.5 | 2.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.5 | 1.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.4 | 4.2 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 3.0 | GO:0050815 | phosphoserine binding(GO:0050815) phosphothreonine binding(GO:0050816) |
0.4 | 2.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.4 | 1.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.4 | 1.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 2.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 8.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 1.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 0.8 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.3 | 5.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 1.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 2.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 4.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 0.8 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.3 | 3.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.2 | 2.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 2.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 9.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 2.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.1 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.2 | 2.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 4.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 2.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.4 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.2 | 3.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 2.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 5.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.2 | 9.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 25.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 2.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 3.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.0 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 3.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 2.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 16.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 0.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.2 | 2.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 50.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 3.4 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 2.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 4.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 3.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.5 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
0.1 | 0.7 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 0.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 3.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 2.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 14.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 5.2 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 1.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 2.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
0.1 | 1.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 3.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 3.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 1.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 2.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 3.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 2.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 5.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 13.1 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 2.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 3.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 5.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 2.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 1.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.7 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.1 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 4.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 10.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 44.8 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 2.8 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 1.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 3.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.0 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 4.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 4.3 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 9.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 5.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 2.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.6 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 2.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 6.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 1.0 | GO:0005525 | GTP binding(GO:0005525) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 37.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 12.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 31.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 9.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 10.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 18.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 7.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 9.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 14.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 53.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 8.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 10.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 3.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 4.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 40.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 5.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 6.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 4.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 8.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 2.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 3.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 3.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 3.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 2.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 16.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 2.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 2.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 16.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 8.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 9.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 7.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 6.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 11.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 4.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 4.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 9.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 3.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 4.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 29.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 11.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 3.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 10.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 3.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 2.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 4.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 2.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 4.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 5.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 3.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 3.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 6.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 4.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 3.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 1.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 6.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 3.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 9.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 2.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 2.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 2.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |